Sage Therapeutics, Inc.
2019 Q4 - 2025 Q2 (23 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q2 | 8/13/2025 | 138 | 0.0% | 15,164 | 6/30/2025 |
| 2025 Q1 | 5/12/2025 | 121 | 0.0% | 15,164 | 3/31/2025 |
| 2024 Q4 | 2/10/2025 | 82 | 0.0% | 15,164 | 12/31/2024 |
| 2024 Q3 | 11/8/2024 | 109 | 0.0% | 15,164 | 9/30/2024 |
| 2024 Q2 | 8/8/2024 | 165 | 0.0% | 15,164 | 6/30/2024 |
| 2024 Q1 | 5/8/2024 | 698 | 0.0% | 16,644 | 3/31/2024 |
| 2023 Q4 | 2/9/2024 | 329 | 0.0% | 15,164 | 12/31/2023 |
| 2023 Q3 | 11/8/2023 | 312 | 0.0% | 15,164 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 705 | 0.0% | 15,004 | 6/30/2023 |
| 2023 Q1 | 6/14/2023 | 698 | 0.0% | 16,644 | 3/31/2023 |
| 2022 Q4 | 6/14/2023 | 635 | 0.0% | 16,644 | 12/31/2022 |
| 2022 Q3 | 11/8/2022 | 829 | 0.0% | 21,164 | 9/30/2022 |
| 2022 Q2 | 8/5/2022 | 684 | 0.0% | 21,164 | 6/30/2022 |
| 2022 Q1 | 5/6/2022 | 2,785 | 0.0% | 84,140 | 3/31/2022 |
| 2021 Q4 | 2/8/2022 | 3,614 | 0.0% | 84,950 | 12/31/2021 |
| 2021 Q3 | 11/8/2021 | 3,785 | 0.0% | 85,412 | 9/30/2021 |
| 2021 Q2 | 8/10/2021 | 5,078 | 0.0% | 89,392 | 6/30/2021 |
| 2021 Q1 | 5/10/2021 | 5,316 | 0.0% | 71,028 | 3/31/2021 |
| 2020 Q4 | 2/8/2021 | 6,815 | 0.0% | 78,778 | 12/31/2020 |
| 2020 Q3 | 11/9/2020 | 4,974 | 0.0% | 81,373 | 9/30/2020 |
| 2020 Q2 | 8/7/2020 | 3,013 | 0.0% | 72,463 | 6/30/2020 |
| 2020 Q1 | 5/5/2020 | 1,961 | 0.0% | 68,266 | 3/31/2020 |
| 2019 Q4 | 2/3/2020 | 4,871 | 0.0% | 67,477 | 12/31/2019 |